Back

Eiffage wins contract to build Just – Evotec Biologics’ first European J.POD® biopharmaceutical production plant in Toulouse

21.10.2022
Scroll
Eiffage wins contract to build Just – Evotec Biologics’ first European J.POD® biopharmaceutical production plant in Toulouse

Evotec Biologics, subsidiary of the German life science group Evotec, to build a biopharmaceutical production facility on its Campus Curie in Toulouse. 

The aim of the future production facility, named “J.POD® Toulouse, France (EU)”, is particularly to accelerate access to biological treatments for European populations. 

The first facility of its kind in Europe, “J.POD® Toulouse, France (EU)” will occupy a three-part building incorporating offices and research labs, a dedicated production area in the middle and a logistics zone. This complex will enhance the existing infrastructure of the German group’s European research and development centre already established on the site. 

Eiffage Construction teams are operating on a general contracting basis on this project, for which they will be using low-carbon concrete. Eiffage Énergie Systèmes is responsible for electrical systems, HVAC (heating, ventilation and air conditioning) installations, plumbing as well as fire safety systems. Eiffage Route will be creating the road network, using Biophalt® plant-based binder for all road surfaces, and is responsible for landscaping and green spaces. 

Works began recently on this cutting-edge production plant which is expected to be operational in the second half of 2024.

This project, which is targeting LEED® Silver certification, benefits from French government funding as part of the Investments for the future Programme (programme d’investissements d’avenir in French) and is also supported economically by the Occitanie Region and Toulouse Métropole.